English

    Overview

  • Ms. Mahima Mohan is a Neuropsychologist in the Department of Neurology in Manipal Hospitals Old Airport Road, Bangalore, with clinical experience in psychological assessment, neuropsychological evaluation and the assessment of cognitive and mental health difficulties. Her clinical interests include dementia, Alzheimer’s disease, frontotemporal dementia, cognitive impairment and changes in memory, attention, executive functioning, language, visuospatial abilities and social cognition. She is committed to supporting comprehensive, evidence-based assessment to help understand the relationship between cognitive functioning, neurological conditions and everyday activities.

  • Ms. Mahima holds a BA in Psychology and an MSc in Clinical Psychology. Her academic background and clinical experience have equipped her with an understanding of psychological functioning, cognitive assessment and neuropsychological evaluation. She has experience conducting standardised cognitive assessments, administering and scoring neuropsychological test batteries, documenting clinical findings and monitoring cognitive functioning in clinical settings.

  • Her areas of expertise include clinical neuropsychological assessment, cognitive assessment and evaluation, psychological assessment and counselling, and the evaluation of cognitive impairment and brain health. She has worked with multidisciplinary teams in the assessment of individuals with neurodegenerative conditions. Her clinical exposure also includes psychological assessment and therapeutic support for individuals experiencing other psychological difficulties. She is particularly interested in evaluating cognitive changes associated with neurological conditions and understanding their impact on daily functioning.

  • Ms. Mahima has actively contributed to clinical research focused on Alzheimer’s disease, dementia and emerging diagnostic and therapeutic approaches. Her research contributions include the study protocol for Plasmapheresis in Alzheimer’s Disease with Replacement by Albumin for Target Management of Neuropathology (PARAM), presented at the Alzheimer’s Association International Conference Neuroscience Next India Hub in Delhi in February 2025. She has also contributed to research presented at the Alzheimer’s Association International Conference (AAIC) in 2025, titled Evaluating Utility of Serum p-tau181 in the Diagnosis of Alzheimer’s Disease and Related Dementias (ADRD) Across Diverse Populations. Her research interests also include blood-based biomarkers and their diagnostic performance across the cognitive continuum in diverse South Asian populations. Her research contributions reflect her interest in advancing the understanding and assessment of neurodegenerative diseases.

  • Through her clinical and research interests, Ms. Mahima aims to support the comprehensive evaluation of individuals experiencing cognitive and psychological difficulties. She values evidence-based practice and multidisciplinary collaboration in understanding cognitive changes, assessing their impact on everyday life and contributing to patient-centred neurological care. She is proficient in English, Malayalam, Hindi and Tamil, enabling her to communicate with patients from diverse linguistic backgrounds.

  • Field of Expertise

  • Clinical Neuropsychological Assessment
  • Cognitive Assessment and Evaluation
  • Psychological Assessment and Counselling
  • Cognitive Impairment and Brain Health
  • Clinical Research and Multidisciplinary Patient Care
  • Languages Spoken

  • English
  • Malayalam
  • Hindi
  • Tamil
  • Talks & Publications

  • Arsahd, F., Kumawat, V., Tripathi, P. P., Mohan, M., Sabu, A., et al. Preventive and therapeutic modality of Plasmapheresis in Alzheimer's disease with Replacement by Albumin for targeted management of neuropathology in mild to moderate illness (PARAM): Study setting and protocol. Alzheimer's & Dementia: Translational Research & Clinical Interventions. Manuscript under review.
  • Diagnostic performance of blood-based biomarker thresholds and ratios across the cognitive continuum in a diverse South Asian cohort. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. Manuscript under review.
  • Plasmapheresis in Alzheimer's Disease with Replacement by Albumin for Target Management of Neuropathology (PARAM): Study Protocol — Alzheimer’s Association International Conference Neuroscience Next India Hub, Delhi, February 2025.
  • Arshad, F., Alladi, S., Subramanian, S., Ramakrishnan, S., Govindaraj, S., Mohan, M., & Thanissery, N. (2025). Evaluating utility of serum p-tau181 in the diagnosis of Alzheimer’s disease and related dementias (ADRD) across diverse populations. Alzheimer’s Association International Conference (AAIC).
  • +N11 Diagnostic performance of blood-based biomarker thresholds and ratios across the cognitive continuum in a diverse South Asian cohort. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. Manuscript under review.

    Languages Spoken

  • English
  • Malayalam
  • Hindi
  • Tamil
  • Overview

  • Ms. Mahima Mohan is a Neuropsychologist in the Department of Neurology in Manipal Hospitals Old Airport Road, Bangalore, with clinical experience in psychological assessment, neuropsychological evaluation and the assessment of cognitive and mental health difficulties. Her clinical interests include dementia, Alzheimer’s disease, frontotemporal dementia, cognitive impairment and changes in memory, attention, executive functioning, language, visuospatial abilities and social cognition. She is committed to supporting comprehensive, evidence-based assessment to help understand the relationship between cognitive functioning, neurological conditions and everyday activities.

  • Ms. Mahima holds a BA in Psychology and an MSc in Clinical Psychology. Her academic background and clinical experience have equipped her with an understanding of psychological functioning, cognitive assessment and neuropsychological evaluation. She has experience conducting standardised cognitive assessments, administering and scoring neuropsychological test batteries, documenting clinical findings and monitoring cognitive functioning in clinical settings.

  • Her areas of expertise include clinical neuropsychological assessment, cognitive assessment and evaluation, psychological assessment and counselling, and the evaluation of cognitive impairment and brain health. She has worked with multidisciplinary teams in the assessment of individuals with neurodegenerative conditions. Her clinical exposure also includes psychological assessment and therapeutic support for individuals experiencing other psychological difficulties. She is particularly interested in evaluating cognitive changes associated with neurological conditions and understanding their impact on daily functioning.

  • Ms. Mahima has actively contributed to clinical research focused on Alzheimer’s disease, dementia and emerging diagnostic and therapeutic approaches. Her research contributions include the study protocol for Plasmapheresis in Alzheimer’s Disease with Replacement by Albumin for Target Management of Neuropathology (PARAM), presented at the Alzheimer’s Association International Conference Neuroscience Next India Hub in Delhi in February 2025. She has also contributed to research presented at the Alzheimer’s Association International Conference (AAIC) in 2025, titled Evaluating Utility of Serum p-tau181 in the Diagnosis of Alzheimer’s Disease and Related Dementias (ADRD) Across Diverse Populations. Her research interests also include blood-based biomarkers and their diagnostic performance across the cognitive continuum in diverse South Asian populations. Her research contributions reflect her interest in advancing the understanding and assessment of neurodegenerative diseases.

  • Through her clinical and research interests, Ms. Mahima aims to support the comprehensive evaluation of individuals experiencing cognitive and psychological difficulties. She values evidence-based practice and multidisciplinary collaboration in understanding cognitive changes, assessing their impact on everyday life and contributing to patient-centred neurological care. She is proficient in English, Malayalam, Hindi and Tamil, enabling her to communicate with patients from diverse linguistic backgrounds.

  • Field of Expertise

  • Clinical Neuropsychological Assessment
  • Cognitive Assessment and Evaluation
  • Psychological Assessment and Counselling
  • Cognitive Impairment and Brain Health
  • Clinical Research and Multidisciplinary Patient Care
  • Talks & Publications

  • Arsahd, F., Kumawat, V., Tripathi, P. P., Mohan, M., Sabu, A., et al. Preventive and therapeutic modality of Plasmapheresis in Alzheimer's disease with Replacement by Albumin for targeted management of neuropathology in mild to moderate illness (PARAM): Study setting and protocol. Alzheimer's & Dementia: Translational Research & Clinical Interventions. Manuscript under review.
  • Diagnostic performance of blood-based biomarker thresholds and ratios across the cognitive continuum in a diverse South Asian cohort. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. Manuscript under review.
  • Plasmapheresis in Alzheimer's Disease with Replacement by Albumin for Target Management of Neuropathology (PARAM): Study Protocol — Alzheimer’s Association International Conference Neuroscience Next India Hub, Delhi, February 2025.
  • Arshad, F., Alladi, S., Subramanian, S., Ramakrishnan, S., Govindaraj, S., Mohan, M., & Thanissery, N. (2025). Evaluating utility of serum p-tau181 in the diagnosis of Alzheimer’s disease and related dementias (ADRD) across diverse populations. Alzheimer’s Association International Conference (AAIC).
  • +N11 Diagnostic performance of blood-based biomarker thresholds and ratios across the cognitive continuum in a diverse South Asian cohort. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. Manuscript under review.

    Field of Expertise

  • Clinical Neuropsychological Assessment
  • Cognitive Assessment and Evaluation
  • Psychological Assessment and Counselling
  • Cognitive Impairment and Brain Health
  • Clinical Research and Multidisciplinary Patient Care
  • Languages Spoken

  • English
  • Malayalam
  • Hindi
  • Tamil
  • Talks & Publications

  • Arsahd, F., Kumawat, V., Tripathi, P. P., Mohan, M., Sabu, A., et al. Preventive and therapeutic modality of Plasmapheresis in Alzheimer's disease with Replacement by Albumin for targeted management of neuropathology in mild to moderate illness (PARAM): Study setting and protocol. Alzheimer's & Dementia: Translational Research & Clinical Interventions. Manuscript under review.
  • Diagnostic performance of blood-based biomarker thresholds and ratios across the cognitive continuum in a diverse South Asian cohort. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. Manuscript under review.
  • Plasmapheresis in Alzheimer's Disease with Replacement by Albumin for Target Management of Neuropathology (PARAM): Study Protocol — Alzheimer’s Association International Conference Neuroscience Next India Hub, Delhi, February 2025.
  • Arshad, F., Alladi, S., Subramanian, S., Ramakrishnan, S., Govindaraj, S., Mohan, M., & Thanissery, N. (2025). Evaluating utility of serum p-tau181 in the diagnosis of Alzheimer’s disease and related dementias (ADRD) across diverse populations. Alzheimer’s Association International Conference (AAIC).
  • +N11 Diagnostic performance of blood-based biomarker thresholds and ratios across the cognitive continuum in a diverse South Asian cohort. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. Manuscript under review.
  • Overview

  • Ms. Mahima Mohan is a Neuropsychologist in the Department of Neurology in Manipal Hospitals Old Airport Road, Bangalore, with clinical experience in psychological assessment, neuropsychological evaluation and the assessment of cognitive and mental health difficulties. Her clinical interests include dementia, Alzheimer’s disease, frontotemporal dementia, cognitive impairment and changes in memory, attention, executive functioning, language, visuospatial abilities and social cognition. She is committed to supporting comprehensive, evidence-based assessment to help understand the relationship between cognitive functioning, neurological conditions and everyday activities.

  • Ms. Mahima holds a BA in Psychology and an MSc in Clinical Psychology. Her academic background and clinical experience have equipped her with an understanding of psychological functioning, cognitive assessment and neuropsychological evaluation. She has experience conducting standardised cognitive assessments, administering and scoring neuropsychological test batteries, documenting clinical findings and monitoring cognitive functioning in clinical settings.

  • Her areas of expertise include clinical neuropsychological assessment, cognitive assessment and evaluation, psychological assessment and counselling, and the evaluation of cognitive impairment and brain health. She has worked with multidisciplinary teams in the assessment of individuals with neurodegenerative conditions. Her clinical exposure also includes psychological assessment and therapeutic support for individuals experiencing other psychological difficulties. She is particularly interested in evaluating cognitive changes associated with neurological conditions and understanding their impact on daily functioning.

  • Ms. Mahima has actively contributed to clinical research focused on Alzheimer’s disease, dementia and emerging diagnostic and therapeutic approaches. Her research contributions include the study protocol for Plasmapheresis in Alzheimer’s Disease with Replacement by Albumin for Target Management of Neuropathology (PARAM), presented at the Alzheimer’s Association International Conference Neuroscience Next India Hub in Delhi in February 2025. She has also contributed to research presented at the Alzheimer’s Association International Conference (AAIC) in 2025, titled Evaluating Utility of Serum p-tau181 in the Diagnosis of Alzheimer’s Disease and Related Dementias (ADRD) Across Diverse Populations. Her research interests also include blood-based biomarkers and their diagnostic performance across the cognitive continuum in diverse South Asian populations. Her research contributions reflect her interest in advancing the understanding and assessment of neurodegenerative diseases.

  • Through her clinical and research interests, Ms. Mahima aims to support the comprehensive evaluation of individuals experiencing cognitive and psychological difficulties. She values evidence-based practice and multidisciplinary collaboration in understanding cognitive changes, assessing their impact on everyday life and contributing to patient-centred neurological care. She is proficient in English, Malayalam, Hindi and Tamil, enabling her to communicate with patients from diverse linguistic backgrounds.

    Talks & Publications

  • Arsahd, F., Kumawat, V., Tripathi, P. P., Mohan, M., Sabu, A., et al. Preventive and therapeutic modality of Plasmapheresis in Alzheimer's disease with Replacement by Albumin for targeted management of neuropathology in mild to moderate illness (PARAM): Study setting and protocol. Alzheimer's & Dementia: Translational Research & Clinical Interventions. Manuscript under review.
  • Diagnostic performance of blood-based biomarker thresholds and ratios across the cognitive continuum in a diverse South Asian cohort. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. Manuscript under review.
  • Plasmapheresis in Alzheimer's Disease with Replacement by Albumin for Target Management of Neuropathology (PARAM): Study Protocol — Alzheimer’s Association International Conference Neuroscience Next India Hub, Delhi, February 2025.
  • Arshad, F., Alladi, S., Subramanian, S., Ramakrishnan, S., Govindaraj, S., Mohan, M., & Thanissery, N. (2025). Evaluating utility of serum p-tau181 in the diagnosis of Alzheimer’s disease and related dementias (ADRD) across diverse populations. Alzheimer’s Association International Conference (AAIC).
  • +N11 Diagnostic performance of blood-based biomarker thresholds and ratios across the cognitive continuum in a diverse South Asian cohort. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. Manuscript under review.
  • Overview

  • Ms. Mahima Mohan is a Neuropsychologist in the Department of Neurology in Manipal Hospitals Old Airport Road, Bangalore, with clinical experience in psychological assessment, neuropsychological evaluation and the assessment of cognitive and mental health difficulties. Her clinical interests include dementia, Alzheimer’s disease, frontotemporal dementia, cognitive impairment and changes in memory, attention, executive functioning, language, visuospatial abilities and social cognition. She is committed to supporting comprehensive, evidence-based assessment to help understand the relationship between cognitive functioning, neurological conditions and everyday activities.

  • Ms. Mahima holds a BA in Psychology and an MSc in Clinical Psychology. Her academic background and clinical experience have equipped her with an understanding of psychological functioning, cognitive assessment and neuropsychological evaluation. She has experience conducting standardised cognitive assessments, administering and scoring neuropsychological test batteries, documenting clinical findings and monitoring cognitive functioning in clinical settings.

  • Her areas of expertise include clinical neuropsychological assessment, cognitive assessment and evaluation, psychological assessment and counselling, and the evaluation of cognitive impairment and brain health. She has worked with multidisciplinary teams in the assessment of individuals with neurodegenerative conditions. Her clinical exposure also includes psychological assessment and therapeutic support for individuals experiencing other psychological difficulties. She is particularly interested in evaluating cognitive changes associated with neurological conditions and understanding their impact on daily functioning.

  • Ms. Mahima has actively contributed to clinical research focused on Alzheimer’s disease, dementia and emerging diagnostic and therapeutic approaches. Her research contributions include the study protocol for Plasmapheresis in Alzheimer’s Disease with Replacement by Albumin for Target Management of Neuropathology (PARAM), presented at the Alzheimer’s Association International Conference Neuroscience Next India Hub in Delhi in February 2025. She has also contributed to research presented at the Alzheimer’s Association International Conference (AAIC) in 2025, titled Evaluating Utility of Serum p-tau181 in the Diagnosis of Alzheimer’s Disease and Related Dementias (ADRD) Across Diverse Populations. Her research interests also include blood-based biomarkers and their diagnostic performance across the cognitive continuum in diverse South Asian populations. Her research contributions reflect her interest in advancing the understanding and assessment of neurodegenerative diseases.

  • Through her clinical and research interests, Ms. Mahima aims to support the comprehensive evaluation of individuals experiencing cognitive and psychological difficulties. She values evidence-based practice and multidisciplinary collaboration in understanding cognitive changes, assessing their impact on everyday life and contributing to patient-centred neurological care. She is proficient in English, Malayalam, Hindi and Tamil, enabling her to communicate with patients from diverse linguistic backgrounds.

  • Field of Expertise

  • Clinical Neuropsychological Assessment
  • Cognitive Assessment and Evaluation
  • Psychological Assessment and Counselling
  • Cognitive Impairment and Brain Health
  • Clinical Research and Multidisciplinary Patient Care
  • Languages Spoken

  • English
  • Malayalam
  • Hindi
  • Tamil

FAQ's

Patients visit Ms. Mahima Mohan, a leading Neuropsychologist at Manipal Hospitals Old Airport Road - Bengaluru, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Ms. Mahima Mohan is a trusted choice for exceptional medical support.

You’re on Our Indian Website

Visit the Global site for International patient services